Search results
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) is a favorite amongst institutional investors who own...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) should be aware of the most powerful...
Eiger BioPharmaceuticals (NASDAQ:EIGR investor five-year losses grow to 55% as the stock sheds...
Simply Wall St. via Yahoo Finance· 2 years agoStatistically speaking, long term investing is a profitable endeavour. But no-one is immune from...
Eiger BioPharmaceuticals (NASDAQ:EIGR) adds US$9.4m to market cap in the past 7 days, though...
Simply Wall St. via Yahoo Finance· 12 months agoEiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shareholders will doubtless be very grateful to see the...
Newsflash: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Analysts Have Been Trimming Their Revenue...
Simply Wall St. via Yahoo Finance· 1 year agoOne thing we could say about the analysts on Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) - they...
Shareholders in Eiger BioPharmaceuticals (NASDAQ:EIGR) are in the red if they invested three years...
Simply Wall St. via Yahoo Finance· 2 years agoEiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shareholders will doubtless be very grateful to see the...
Loss-Making Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Expected To Breakeven In The Medium-Term
Simply Wall St. via Yahoo Finance· 1 year agoWith the business potentially at an important milestone, we thought we'd take a closer look at Eiger...
Things Look Grim For Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) After Today's Downgrade
Simply Wall St. via Yahoo Finance· 2 years agoThe analysts covering Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) delivered a dose of negativity to...
The Scientific Founder & Independent Director of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR),...
Simply Wall St. via Yahoo Finance· 1 year agoPotential Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shareholders may wish to note that the...
Investors Holding Back On Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)
Simply Wall St. via Yahoo Finance· 11 months agoWith a price-to-sales (or "P/S") ratio of 3.4x Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) may be...
Eiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related...
Benzinga via Yahoo Finance· 1 year agoEiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced the publication of data from the...